Ventricular Tachycardia (VT) is a cardiac arrhythmia characterized by a rapid and regular heartbeat originating in the heart's lower chambers, the ventricles. In VT, the heart beats at a significantly faster rate than normal, disrupting its regular rhythm. This condition poses serious health risks as it may lead to inadequate blood flow to the body and, in severe cases, progress to more life-threatening arrhythmias. Ventricular Tachycardia can occur in individuals with pre-existing heart conditions, such as coronary artery disease or structural heart abnormalities, but it can also manifest in those with otherwise healthy hearts. Prompt diagnosis and management are crucial to prevent complications and improve patient outcomes, often involving anti-arrhythmic medications, catheter ablation, or, in severe cases, implantable cardioverter-defibrillator (ICD) placement. Regular monitoring and collaboration between healthcare professionals play a vital role in effectively addressing Ventricular Tachycardia and ensuring the well-being of affected individuals.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia